• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Impact of serum sulfatide level or micro RNA on coronary plaque vulnerability or restenosis post percutaneous coronary intervention

Research Project

Project/Area Number 15K09094
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Cardiovascular medicine
Research InstitutionDokkyo Medical University

Principal Investigator

Taguchi Isao  獨協医科大学, 医学部, 教授 (80316570)

Co-Investigator(Kenkyū-buntansha) 小松 孝昭  獨協医科大学, 医学部, 講師 (10597537)
井上 晃男  獨協医科大学, 医学部, 教授 (20168454)
中原 志朗  獨協医科大学, 医学部, 准教授 (70383081)
京ヶ島 守  日本薬科大学, 薬学部, 教授 (50225091)
Project Period (FY) 2015-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords冠動脈疾患 / カテーテル治療 / 再狭窄 / プラーク / 冠動脈形成術 / micro RNA / スルファチド / 酸化ストレス
Outline of Final Research Achievements

The present study demonstrated that a balloon alone percutaneous coronary intervention (PCI) using drug coated balloon or ‘Stent-less PCI’ exhibited equivalent effects compared to PCI with drug eluting stents in coronary artery disease patients. After ‘Stent-less PCI’, anti-thrombotic agents can be reduced safely, because stent thrombosis or neo-atherosclerosis can be prevented. Therefore, coronary events and bleeding events will be prevented simultaneously and long term prognosis can be improved. In patients received ‘Stent-less PCI’ who plan to undergo non-cardiac surgeries, anti-thrombotic agents can be discontinued safely, and bleeding complications can be reduced. Additionally, when a patient after ‘Stent-less PCI’ will need coronary artery bypass grafting (CABG) in the future, there will be no coronary stent that might interfere in CABG.
‘Stent-less PCI’ should be performed in the patients whose coronary artery lesions can be dilated optimally only with balloon.

Report

(4 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • 2015 Research-status Report
  • Research Products

    (4 results)

All 2017 2016

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Acknowledgement Compliant: 1 results) Presentation (2 results) (of which Invited: 1 results)

  • [Journal Article] 心血管インターベンション治療における 抗血栓療法の新たな展開2017

    • Author(s)
      小松孝昭、田口功
    • Journal Title

      心血管薬物療法

      Volume: 5 Pages: 39-48

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Clinical value of drug-coated balloon angioplasty for de novo lesions in patients with coronary artery disease2016

    • Author(s)
      Naoki Nishiyama, Takaaki Komatsu, Takanori Kuroyanagi, Akinori Fujikake, Sachiko Komatsu, Hidehiko Nakamura, Kota Yamada, Shiro Nakahara, Sayuki Kobayashi, Isao Taguchi
    • Journal Title

      International Journal of Cardiology

      Volume: 222 Pages: 113-118

    • DOI

      10.1016/j.ijcard.2016.07.156

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Presentation] 新規冠動脈疾患患者に対するdrug-coated balloon (DCB) の臨床的有用性2016

    • Author(s)
      7.西山直希、小松孝昭、黒栁享義、藤掛彰則、小松禎子、中村日出彦、山田康太、中原志朗、小林さゆき、酒井良彦、田口 功
    • Organizer
      第53回日本臨床生理学会総会 ミニシンポジウム
    • Place of Presentation
      砂防会館(東京都千代田区)
    • Year and Date
      2016-10-28
    • Related Report
      2016 Research-status Report
    • Invited
  • [Presentation] 慢性冠動脈病変に対するdrug coated balloonの有用性の検討2016

    • Author(s)
      西山直希、田口 功、ほか
    • Organizer
      第64回日本心臓病学会学術集会
    • Place of Presentation
      東京国際フォーラム(東京都千代田区)
    • Year and Date
      2016-09-23
    • Related Report
      2016 Research-status Report

URL: 

Published: 2015-04-16   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi